Xiu‐E Xu

2.6k citations

73 papers · 1.7k indexed · h-index 25

Molecular Biology top 10%
Cancer Research top 5%
Oncology top 10%
Pulmonary and Respiratory Medicine top 10%
Surgery top 10%

Co-authors: En‐Min Li Li‐Yan Xu Lian‐Di Liao Jian‐Yi Wu Zhi‐Yong Wu Jianzhong He Jin‐Hui Shen Jian‐Jun Xie
Topics: Esophageal Cancer Research and Treatment (20 papers)Cancer-related gene regulation (12 papers)Cell Adhesion Molecules Research (11 papers)
Cited by: Cancer Research Immunology and Allergy Molecular Biology
Journals: Nucleic Acids Research PLoS ONE Cancer Research
Partner nations: China Canada United States

In The Last Decade

Xiu‐E Xu

73 papers receiving 1.7k citations

Peers

Countries citing papers authored by Xiu‐E Xu

Since Specialization

Citations

This map shows the geographic impact of Xiu‐E Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiu‐E Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiu‐E Xu more than expected).

Fields of papers citing papers by Xiu‐E Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiu‐E Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiu‐E Xu. The network helps show where Xiu‐E Xu may publish in the future.

Co-authorship network of co-authors of Xiu‐E Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiu‐E Xu. A scholar is included among the top collaborators of Xiu‐E Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiu‐E Xu. Xiu‐E Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery and validation of combined biomarkers for the diagnosis of esophageal intraepithelial neoplasia and esophageal squamous cell carcinoma 2024 ·Journal of Proteomics ·(unknown),Haihua Huang,Shuxian Chen,Xiu‐E Xu,(unknown),Yuehong Li,(unknown),(unknown),(unknown),Wei Liu,En‐Min Li,Li‐Yan Xu	1
2	Acetyl-CoA Acetyltransferase 2 Confers Radioresistance by Inhibiting Ferroptosis in Esophageal Squamous Cell Carcinoma 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown),(unknown),Luxin Liu,(unknown),(unknown),Xiu‐E Xu,Lian‐Di Liao,(unknown),He-Cheng Huang,En‐Min Li,Li‐Yan Xu	11
3	Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer 2023 ·Journal of Experimental & Clinical Cancer Research ·Jianzhong He,Yang Chen,Fa‐Min Zeng,Qingfeng Huang,Haifeng Zhang,Shaohong Wang,(unknown),Xiaoxiao Pang,Ye Liu,Xiu‐E Xu,Jian‐Yi Wu,Wen‐Jun Shen,(unknown),En‐Min Li,Li‐Yan Xu	17
4	Blocking STAT3 signaling augments MEK/ERK inhibitor efficacy in esophageal squamous cell carcinoma 2022 ·Cell Death and Disease ·(unknown),(unknown),Wan‐Wan Lin,(unknown),Xiu‐E Xu,Yang Chen,Lian‐Di Liao,Zhiyong Wu,Shaohong Wang,En‐Min Li,Li‐Yan Xu	20
5	Cisplatin-induced pyroptosis is mediated via the CAPN1/CAPN2-BAK/BAX-caspase-9-caspase-3-GSDME axis in esophageal cancer 2022 ·Chemico-Biological Interactions ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Xiu‐E Xu,Lian‐Di Liao,Wan‐Wan Lin,(unknown),He-Cheng Huang,En‐Min Li,Li‐Yan Xu	41
6	Development and Validation of a New Staging System for Esophageal Squamous Cell Carcinoma Patients Based on Combined Pathological TNM, Radiomics, and Proteomics 2022 ·Annals of Surgical Oncology ·(unknown),(unknown),Tian‐Tian Zhai,Xiu‐E Xu,(unknown),(unknown),En‐Min Li,Wei Liu,Li‐Yan Xu	4
7	Effect of vasodilator PGE1 on sciatic nerve function, VEGF level, vascular permeability and peripheral nerve in type 2 diabetic rats 2021 ·Tropical Journal of Pharmaceutical Research ·Fang Wang,(unknown),Xiu‐E Xu,Yuan Chen,(unknown)	1
8	P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer 2021 ·Cancer Communications ·Yinwei Cheng,Fa‐Min Zeng,(unknown),Shaohong Wang,Jianzhong He,(unknown),(unknown),Zhi‐Yong Wu,Wenqi Shi,Bing Wen,Xiu‐E Xu,Lian‐Di Liao,(unknown),Jian‐Yi Wu,Jun Zhan,Hongquan Zhang,Zhijie Chang,Kai Zhang,Li‐Yan Xu,En‐Min Li	22
9	LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion 2019 ·Cancer Research ·(unknown),Jiwei Jiao,Haifeng Zhang,Xiu‐E Xu,Jianzhong He,(unknown),Haiying Zou,Zhi‐Yong Wu,Shaohong Wang,Jian‐Yi Wu,Lian‐Di Liao,Sheng Wang,Yinwei Cheng,Kai Zhang,Gera Neufeld,Li‐Yan Xu,En‐Min Li	53
10	MASAN: a novel staging system for prognosis of patients with oesophageal squamous cell carcinoma 2018 ·British Journal of Cancer ·(unknown),Jianzhong He,Shaohong Wang,(unknown),Xuefeng Bai,Xiu‐E Xu,Jian‐Yi Wu,Yong Jiang,Chunquan Li,Longqi Chen,En‐Min Li,Li‐Yan Xu	12
11	Riboflavin Depletion Promotes Tumorigenesis in HEK293T and NIH3T3 Cells by Sustaining Cell Proliferation and Regulating Cell Cycle–Related Gene Transcription 2018 ·Journal of Nutrition ·Lin Long,Jianzhong He,Ye Chen,Xiu‐E Xu,Lian‐Di Liao,Yang‐Min Xie,En‐Min Li,Li‐Yan Xu	18
12	Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma 2018 ·Clinics and Research in Hepatology and Gastroenterology ·Yi‐Wei Xu,Chao‐Qun Hong,Zhi‐Yong Wu,Yu‐Hui Peng,(unknown),(unknown),(unknown),Xiaoying Liang,(unknown),Jian‐Yi Wu,Xiu‐E Xu,Jianwen Deng,Haiying Zou,Wang‐Kai Fang,En‐Min Li,Li‐Yan Xu,Jian‐Jun Xie	6
13	SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer 2018 ·Cellular and Molecular Life Sciences ·Lin Long,Xiaoxiao Pang,Fei Lei,Jiasheng Zhang,Wei Wang,Lian‐Di Liao,Xiu‐E Xu,Jianzhong He,Jian‐Yi Wu,Zhi‐Yong Wu,Lidong Wang,De‐Chen Lin,En‐Min Li,Li‐Yan Xu	42
14	Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Zepeng Du,Bingli Wu,Yang‐Min Xie,Yingli Zhang,Lian‐Di Liao,Fei Zhou,Jian‐Jun Xie,Fa‐Min Zeng,Xiu‐E Xu,Wang‐Kai Fang,En‐Min Li,Li‐Yan Xu	28
15	Altered expression and localization of desmoglein 3 in esophageal squamous cell carcinoma 2014 ·Acta Histochemica ·Wang‐Kai Fang,Bo Chen,Xiu‐E Xu,Lian‐Di Liao,Zhi‐Yong Wu,Jian‐Yi Wu,Jian Shen,Li‐Yan Xu,En‐Min Li	10
16	DACT2 Is a Candidate Tumor Suppressor and Prognostic Marker in Esophageal Squamous Cell Carcinoma 2013 ·Cancer Prevention Research ·Jian Hou,Lian‐Di Liao,Yang‐Min Xie,Fa‐Min Zeng,Xia Ji,Bo Chen,Liyan Li,Mengxiao Zhu,Cuixia Yang,(unknown),(unknown),Xiu‐E Xu,Jian Shen,Mingzhou Guo,En‐Min Li,Li‐Yan Xu	22
17	miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2 2013 ·Carcinogenesis ·Haifeng Zhang,Kai Zhang,Lian‐Di Liao,Liyan Li,Zepeng Du,Bingli Wu,Jian‐Yi Wu,Xiu‐E Xu,Fa‐Min Zeng,Bo Chen,Huihui Cao,Mengxiao Zhu,Lihua Dai,Lin Long,Zhiyong Wu,Raymond Lai,Li‐Yan Xu,En‐Min Li	47
18	Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma 2012 ·Acta Histochemica ·Lingling Sun,(unknown),Xiu‐E Xu,Mengxiao Zhu,Zhi‐Yong Wu,Jin‐Hui Shen,Jian‐Yi Wu,Qiao Huang,En‐Min Li,Li‐Yan Xu	26
19	Prognostic implication of ezrin expression in esophageal squamous cell carcinoma 2011 ·Journal of Surgical Oncology ·Jian‐Jun Xie,Li‐Yan Xu,Zhi‐Yong Wu,Qing Zhao,Xiu‐E Xu,Jian‐Yi Wu,Qiao Huang,En‐Min Li	33
20	Original article: The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features 2010 ·Diseases of the Esophagus ·(unknown),Haijun Zhong,(unknown),Xin Huang,Lian‐Di Liao,(unknown),Xiu‐E Xu,Zhong‐Ying Shen,Li‐Yan Xu,En‐Min Li	64

About Xiu‐E Xu

Xiu‐E Xu is a scholar working on Immunology and Allergy, Oncology and Cancer Research, having authored 73 papers that have together received 1.7k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (20 papers), Cancer-related gene regulation (12 papers) and Cell Adhesion Molecules Research (11 papers). The work is most often cited by research in Cancer Research (483 citations), Immunology and Allergy (103 citations) and Molecular Biology (1.2k citations). Xiu‐E Xu has collaborated with scholars based in China, Canada and United States. Frequent co-authors include En‐Min Li, Li‐Yan Xu, Lian‐Di Liao, Jian‐Yi Wu, Zhi‐Yong Wu, Jianzhong He, Jin‐Hui Shen, Jian‐Jun Xie, Shaohong Wang and Yang‐Min Xie. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact